Advertisement

Topics

Targeted Diagnostics and Therapeutics Company Profile

10:51 EST 10th December 2018 | BioPortfolio

TDT has emerged as a leader in the development of innovative molecular diagnostics and therapeutics that can improve the quality of life of patients with colorectal cancer and gastrointestinal malignancies. Focused on innovative research and cutting edge technology, TDT has developed highly specific tests to detect colorectal cancer cells in lymph nodes from patients who have undergone surgical staging for colorectal cancer. The information derived from this test can assist physicians in making decisions about the administration of chemotherapy to improve disease-free survival. A similar test has been developed for the detection of circulating colorectal cancer cells in blood. This determines that patients undergoing post-operative surveillance for recurrent colorectal cancer remain free of disease. Intensive research and development is being conducted on treating metastatic colorectal cancer with novel therapeutic agents specifically targeted only to those cancer cells.

Location

1045 Andrew Drive
West Chester
PA
19380
United States of America

Contact

Phone: (610) 431 0800
Fax: (610) 431 0805
Email: info@tdtinc.com


News Articles [1802 Associated News Articles listed on BioPortfolio]

Global $85.5 Billion Precision Medicine (Diagnostics/Therapeutics) Market to 2025 - Key Players ...

DUBLIN, Nov. 16, 2018 /PRNewswire/ -- The "Precision Medicine (Diagnostics/Therapeutics) Market Analysis Report By Application (Genetic Tests, Esoteric Tests, Pharmaceuticals, Medical Devices), By End...

Global Kidney Cancer Therapeutics & Diagnostics Market (2018-2023): Rising Number of Kidney Cancer Cases is Driving Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Kidney Cancer Therapeutics & Diagnostics Market – Segmented by Cancer Type, Therapy, Diagnostics, End-users, and Geography – Growt...

Five Prime gets companion diagnostics from Roche

Roche and Five Prime Therapeutics Inc. agreed to develop, validate, and sell tissue-based immunohistochemistry (IHC) companion diagnostics that will identify the most likely responders to Five Prime...

Carrick licenses targeted ovarian cancer drug from BTG

Dublin, Ireland-based biopharma Carrick Therapeutics has licensed exclusive globl rights to develop and commercialise BTG’s targeted ovarian cancer drug BTG945.

Gilead and Tango Therapeutics Announce Strategic Collaboration to Develop Next-Generation Targeted Immuno-Oncology Therapies

FOSTER CITY, Calif. & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) and Tango Therapeutics, Inc., a company focused on the discovery and development of novel ca...

Novel Oral-targeted Therapies in Inflammatory Bowel Disease

This article presents an overview of recent clinical trials for next generation oral targeted medications that show promise in the management of inflammatory bowel disease. Alimentary Pharmacology &...

Strand Life Sciences to acquire Quest Diagnostics' Indian diagnostics business

Quest Diagnostics, the world's leading provider of diagnostic information services, announced an agreement to sell its India medical diagnostics business to Strand Life Sciences, a Bengaluru─based s...

TP Therapeutics Names New CEO, Gets $80M More for Cancer Drug Push

Five-year-old biotech TP Therapeutics has raised an $80 million mezzanine financing round and promoted its chief medical officer, Athena Countouriotis, to CEO. The San Diego-based biotech, which is de...

PubMed Articles [1349 Associated PubMed Articles listed on BioPortfolio]

RNA-targeted therapeutics for lipid disorders.

To summarize recent developments in the field of RNA-directed therapeutics targeting lipid disorders that are not effectively managed.

Omics, big data and machine learning as tools to propel understanding of biological mechanisms and to discover novel diagnostics and therapeutics.

Molecular targeted therapy: treating cancer with specificity.

Molecular targeted therapies are revolutionized therapeutics which interfere with specific molecules to block cancer growth, progression and metastasis. Many molecular targeted therapies approved by t...

A paradigm shift for prostate cancer diagnostics.

The current praxis of diagnosing prostate cancer, with systematic prostate biopsies in men with raised serum prostate-specific antigen (PSA) levels, leads to considerable over-diagnosis and over-treat...

Peptide-based targeted therapeutics: Focus on cancer treatment.

Therapeutic peptides are attracting increasing attention for biomedical applications. Peptides present promising opportunities in targeted drug delivery due to their high specificity, selectivity, sma...

Clinical Trials [1632 Associated Clinical Trials listed on BioPortfolio]

Multi-Drug Resistant Organism Network

This study is specifically designed to provide observational data which can be used to help in the design of future randomized clinical trials on both therapeutics and diagnostics for MDRO...

Cohort Study for Patients Using Fuzeon (Enfuvirtide)

The Radata-Fuzeon cohort is an observational cohort study to gain a better understanding of Fuzeon (Enfuvirtide) in daily clinical practice. Patients planned to take this drug in a new ant...

Economic Evaluation of Innovative Molecular Analyses in Onco-haematology

To evaluate the impact of innovative molecular diagnostics on the clinical management of patients with haematological malignancies via updated Appropriate-Prescribing-Guides including Next...

Differential Diagnostics of Etiology of Acute Infections

Method for diagnostics of the origin of infections (bacterial vs viral) based on the identification of activation markers of blood neutrophils and monocytes will be developed.

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

Companies [2624 Associated Companies listed on BioPortfolio]

Affibody

Affibody has developed a unique pipeline of affinity ligands in oncology, covering the entire value chain from research reagents to molecular imaging agents and targeted therapeutics. The company has ...

Targeted Diagnostics and Therapeutics

TDT has emerged as a leader in the development of innovative molecular diagnostics and therapeutics that can improve the quality of life of patients with colorectal cancer and gastrointestinal maligna...

Advanced Cell Diagnostics, Inc.

Advanced Cell Diagnostics, Inc. (ACD) is a leader in the emerging field of molecular pathology, developing cell- and tissue-based diagnostic tests for personalized medicine. The company's products and...

Vaxiion Therapeutics, Inc.

Vaxiion is dedicated to the design and development of intelligent drug-delivery technologies with special emphasis on targeted oncology therapeutics. Vaxiion Therapeutics was spun...

U3 Pharma AG

U3 Pharma AG is an emerging leader in targeted cancer drug development. The company has produced a pipeline of novel targeted therapeutics based on the ground-breaking discoveries made by its founder ...

More Information about "Targeted Diagnostics and Therapeutics" on BioPortfolio

We have published hundreds of Targeted Diagnostics and Therapeutics news stories on BioPortfolio along with dozens of Targeted Diagnostics and Therapeutics Clinical Trials and PubMed Articles about Targeted Diagnostics and Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Targeted Diagnostics and Therapeutics Companies in our database. You can also find out about relevant Targeted Diagnostics and Therapeutics Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Gastroenterology
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...


Corporate Database Quicklinks



Searches Linking to this Company Record